Hijacking Human Rights in Latin America
By Gina Maranto, Biopolitical Times guest contributor
| 05. 03. 2011
In 2009, a Buenos Aires civic association awarded a prize named after American civil rights activist Rosa Parks to Argentinian Senator Liliana Negre de Alonso. The prize was given “por la Defensoría de la Vida Humana,” but the recipient’s resumé hardly resembles that of a typical human rights advocate. Negre de Alonso has a history of opposing laws and policies that favor sexual and reproductive choice. In 2006, for instance, she fought against a bill that sought to provide all Argentinians access to free vasectomies or tubal ligations. Among other things, she argued that it would promote HIV transmission by lessening the need for condoms. She has long opposed abortion, and last year, she waged a highly emotional campaign against Argentina’s landmark same-sex marriage law.
Negre de Alonso, a member of the highly conservative Opus Dei movement, which defines itself as the “personal prelature of the Catholic Church”, was exhibit Number One in a recent talk by anthropologist Lynn Morgan at the University of Miami. Morgan, the Mary E. Woolley Professor of Anthropology at...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...